𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of the anti-ebv titer and the ebv-associated membrane reactive and precipitating antibody levels in the sera of burkitt lymphoma and nasopharyngeal carcinoma patients and controls

✍ Scribed by G. Klein; G. Geering; L. J. Old; G. Henle; W. Henle; P. Clifford


Publisher
John Wiley and Sons
Year
1970
Tongue
French
Weight
763 KB
Volume
5
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Comparisons were made between 151 sera from 131 donors with Burkitt's lymphoma, nasopharyngeal carcinoma and other tumors of the head and neck area, from patients having had infectious mononucleosis and from healthy controls, in three EBV‐associated serological tests: intracellular immunofluorescence on fixed smears of EBV‐carrying lymphoblastoid cell lines (“anti‐EBV‐reaction”), blocking of membrane fluorescence on similar lines and immunoprecipitation against the soluble antigen extracted from the EBV‐carrying P3J culture line. Anti‐EBV and membrane blocking antibody levels showed concordant patterns in 122 sera (81%) and discordant in 29 (19%), in agreement with previous results. If the anti‐EBV and the precipitin tests are compared, 81.5% of the sera gave concordant and 18.5 discordant results. Blocking of membrane reactivity gave concordant results with the precipitin test in 71.5% of the sera whereas 28.5% were discordant. All three tests gave concordant results in 67% of the serum material; this figure fits expectations if it is assumed that the probability of an association between the anti‐EBV titer and the membrane blocking antibody level is independent of the probability of an association between the anti‐EBV titer and the antibody detected by the precipitin test. Analysis of the serological patterns in relation to disease categories shows that the sera of patients with head and neck tumors other than carcinoma of the post‐nasal space or Burkitt's lymphoma fell mainly within the low reactive categories. Sera from nasopharyngeal carcinoma and African Burkitt lymphoma patients showed the opposite behavior, with a majority of highly reactive sera according to all three tests. Most control sera were negative or low in all three tests. In one Burkitt patient, the serological findings could be related to the clinical course of the disease; high membrane reactive antibody levels were seen in the course of tumor regression, but fell to low levels before and immediately after recurrence. Precipitating antibodies showed the opposite pattern, being absent during regression and highly positive after recurrence.


📜 SIMILAR VOLUMES


Comparison of plasma Epstein–Barr virus
✍ Jian-Yong Shao; Yu-Hong Li; Hong-Yi Gao; Qiu-Liang Wu; Nian-Ji Cui; Li Zhang; Ga 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 2 views

## Abstract ## BACKGROUND Serologic measurement of antibodies to Epstein–Barr virus (EBV) immunoglobulin A/viral capsid antigen (IgA/VCA) and early antigen (IgA/EA) has been used widely to screen for nasopharyngeal carcinoma (NPC) in China. Recently, it was found that plasma EBV DNA concentration

A comparison of the prognostic value of
✍ S. H. Chan; P. H. Levine; G. B. De-Thé; S. E. Mulroney; M. F. Lavoue; S. P. P. G 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 French ⚖ 475 KB

## Abstract Antibody titres to EBV‐associated antigens in Chinese NPC patients were analysed according to length of survival after diagnosis and to disease stage. Geometric mean titres of ADLC antibody were highest in the long‐term survivors, whereas VCA, EA and EBNA antibody titres showed an inver

The Epstein-Barr Virus (EBV) major envel
✍ Jingwu Xu; Ali Ahmad; Marie Blagdon; Mario D'Addario; James F. Jones; Riccardo D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB 👁 1 views

gp350 of Epstein-Barr virus (EBV) induces a strong immune response in EBV-infected individuals, but relatively little is known about the clinical relevance of this response in patients with different EBV-associated malignancies and other diseases. Using our gp350-expressing cell clones, we studied g

Prevalence of mutations and 30-bp deleti
✍ Suet Y. Leung; Siu T. Yuen; Lap P. Chung; Annie S.Y. Chan; Maria P. Wong 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 70 KB 👁 2 views

A specific variant of Epstein-Barr virus (EBV) with a 30-bp deletion in the C-terminal region of the LMP1 gene has been found in some EBV-associated malignancies. To better understand the tumorigenic role of this LMP1 variant, we used PCR and sequencing to examine the LMP1 gene in 38 EBVassociated c